FOR IMMEDIATE RELEASE
On March 30th, 2016, the FDA, under the guidance of the Obama administration, made big changes to the rules regarding the use of chemical abortions.
Many on the pro-choice side are claiming this move was to expand women’s abortion access. However, in a new video series by Life Dynamics called The Real Story, President Mark Crutcher states that abortion clinics have been providing chemical abortions at one-third dosages for pregnancies that were well past the cut-off date since day one. He reveals that the real reason for the FDA’s decision was to protect abortion industry profits.
Crutcher adds that the abortion industry realized that smaller doses and performing them at much later stages of pregnancy is “a gold mine.”
“One-third dosages increase profits, and using it past the specified cut off date grows the customer base.”
But with such measures come increased risks and complications.
Life Dynamics knows this perhaps better than anybody. For the past 20 years, the pro-life organization has been providing litigation support services to attorneys who sue on behalf of women who have been killed, injured or sexually assaulted while having abortions. Traditionally, incomplete abortions accounted for a small number of cases that they assisted with. But after chemical abortions came on the market, the number of cases they saw exploded.
“Well-over 90 percent of the calls we get from abortion-injured women involved incomplete or missed abortions. Of course, the problems associated with these instances are not merely dangerous for the women involved, they are potentially fatal.”
So what happens when a woman goes in for a chemical abortion and it is incomplete or completely fails? A surgical abortion, paid for by the woman, is the next step.
“Whenever one of their chemical abortions fail, the abortion industry gets to sell a second abortion. That’s two profits for just killing one baby.”
But if the abortion industry has been performing chemical abortions like this for years, then how does the new FDA chemical abortion guidelines protect industry profits? Because previously, the abortion industry was ignoring the drug manufacturer’s protocol and, as a result, they were exposed to a high risk of being sued for medical malpractice. But thanks to the FDA that problem has been solved.
Life Dynamics’ new video can be watched below.
To learn more about Life Dynamics and read Mark’s bio, visit: https://lifedynamics.com/about-us/
Those wanting media interviews should contact Sheila Crutcher at (940) 380-8800.